Operating Expenses

Stock-based compensation expense

Medtronic Stock-based compensation expense increased by 55.3% to $146.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from $152.00M to $146.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ3 2026Feb 24, 2026

How to read this metric

Rising expenses may indicate increased reliance on equity incentives or higher valuation of awards, impacting reported operating margins.

Detailed definition

This metric measures the total expense recognized in the income statement for share-based payment awards granted to empl...

Peer comparison

Standard operating expense item for public companies with equity incentive programs.

Metric ID: cat_stock_based_compensation_expense

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$107.00M$92.00M$49.00M$41.00M$55.00M$48.00M$73.00M$35.00M$49.00M$87.00M$103.00M$152.00M$93.00M$94.00M$146.00M
QoQ Change-14.0%-46.7%-16.3%+34.1%-12.7%+52.1%-52.1%+40.0%+77.6%+18.4%+47.6%-38.8%+1.1%+55.3%
YoY Change-61.7%-40.2%-2.0%+78.0%-36.4%+2.1%+19.2%+194.3%+210.2%+6.9%-8.7%-3.9%
Range$35.00M$152.00M
CAGR+9.3%
Avg YoY Growth+29.8%
Median YoY Growth+0.0%
Current Streak2 quarters growth

Stock-based compensation expense at Other Companies

Frequently Asked Questions

What is Medtronic's stock-based compensation expense?
Medtronic (MDT) reported stock-based compensation expense of $146.00M in Q4 2025.
How has Medtronic's stock-based compensation expense changed year-over-year?
Medtronic's stock-based compensation expense decreased by 3.9% year-over-year, from $152.00M to $146.00M.
What does stock-based compensation expense mean?
The total expense recorded for employee stock awards.